Melinta Therapeutics, Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • Bioinformatics
  • Pharmaceuticals

Other Names/Subsidiaries

  • Rib-X Pharmaceuticals, Inc.
  • Cempra, Inc. (Cempra Pharmaceuticals, Inc.)
See more in Biomedtracker

Latest on Melinta Therapeutics, Inc.

Scrip

Best Practices For Offering Value To Potential Partners – Highlights From LSX

 
• By Joseph Haas

With the flow of initial public offerings frustratingly sluggish and a tight financing environment, biopharma companies are looking for advice on other ways to bring in funding capital or explore busi

Pink Sheet

Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer’s Hemophilia B Gene Therapy

 
• By Bridget Silverman

The US Food and Drug Administration approvals of Day One Biopharmaceuticals, LLC ’s Ojemda (tovorafenib) and ImmunityBio Inc. ’s Anktiva (nogapendekin alfa inbakicept-pmln) last week provided a boos

Scrip

Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative

 
• By Joseph Haas

Cidara Therapeutics, Inc. took a series of steps 24 April that completely reinvent the company, essentially forming a new company with a new focus, Cidara CEO Jeffrey Stein said in an interview. Abou

Pink Sheet

Marching On: Eight Novel Agents Among March Goal Dates For US FDA

 
• By Bridget Silverman

The month of March will bring eight more chances for the US FDA to approve novel drugs and biologics, potentially providing a corrective to 2024’s slow start for innovative approvals. The number of us